EZH2 and hepatocellular carcinoma: came to the identical conclusion, demonstrating that genetic or pharmacological inhibition of EZH2 induces re-expression of chemokine CXCL10 in HCC and therefore promotes migration and infiltration of NK cells into the tumor (118).